Christopher West, MD
Hospice and Palliative Medicine · Flemington, NJNPI 1295295533
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Lundbeck LLC at 21.2% of the total. 2025 is the largest year on record at $88, 2.6 times the $34 reported in 2023.
Across 10 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$37
- Eisai Inc.$36
- Lilly USA, LLC$33
- Otsuka America Pharmaceutical, Inc.$21
- Acadia Pharmaceuticals Inc$18
- Teva Pharmaceuticals USA, Inc.$17
- plus $13 from 1 others
What the payments were for
- Food & beverage$176100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 2 | $37 |
| Eisai Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Acadia Pharmaceuticals Inc | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Pfizer | 1 | $13 |
How this compares
$176 in reported general payments places this provider in the 60th percentile of 38 hospice and palliative medicine providers in New Jersey.
See all hospice and palliative medicine providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 16 | $11,457 |
| Fentanyl | 32 | $2,681 |
| Morphine Sulfate | 25 | $1,312 |
| Hydromorphone Hcl | 34 | $974 |
| Oxycodone Hcl | 40 | $891 |
| Methadone Hcl | 16 | $537 |
| Gabapentin | 32 | $339 |
| Bupropion XlBupropion Hcl | 25 | $273 |
| Lorazepam | 17 | $85 |
| Pantoprazole Sodium | 14 | $30 |
| Metoclopramide Hcl | 12 | $26 |
Paid to pharmacies, not to this prescriber.
Other hospice and palliative medicine in Flemington
- Stacey Rifkin-ZenenbergHackensack$19K
- Kenneth AdessaParsippany$16K
- Ramy SedhomPlainsboro$3K
- Anjali DesaiMorristown$3K
- Keith PasichowLong Branch$834
- Ilene LauferWest New York$666
- Vandana SharmaNeptune$653
- Christopher BolichCamden$583
- Maria ShindlerMorristown$514
- Felix PachecoParamus$408
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.